FBP1 and nonpapillary renal cell carcinoma: Pan-metabolomic analysis has been used to show that the FBP1 protein was inhibited in both clear cell renal cell carcinoma (ccRCC) tumors and hepatocellular carcinomas; moreover, this disappearance was not regulated by HIF activation and exhibited the tumor-suppressive functions of FBP1.